Occurrence and Risk of Cochleotoxicity in Cystic Fibrosis Patients Receiving Repeated High-Dose Aminoglycoside Therapy

Cystic fibrosis (CF) patients receive repeated courses of aminoglycoside therapy. These patients would consequently be expected to be more susceptible to cochleotoxicity, a recognized side effect with single courses of aminoglycoside therapy. The primary aim of this retrospective study was to establ...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Mulheran, M., Degg, C., Burr, S., Morgan, D. W., Stableforth, D. E.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2001
Assuntos:	Clinical Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90684/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11502521/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.9.2502-2509.2001
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!